Royal Bank of Canada’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Buy
58
+12
+26% +$33 ﹤0.01% 7344
2025
Q4
$0 Sell
46
-6,098
-99% -$32.9K ﹤0.01% 7328
2025
Q3
$26K Buy
6,144
+5,104
+491% +$18.1K ﹤0.01% 6101
2025
Q2
$3K Sell
1,040
-4,260
-80% -$11.3K ﹤0.01% 6735
2025
Q1
$15K Buy
5,300
+4,300
+430% +$16.1K ﹤0.01% 6010
2024
Q4
$2K Hold
1,000
﹤0.01% 6710
2024
Q3
$2K Sell
1,000
-13,789
-93% -$30.4K ﹤0.01% 6641
2024
Q2
$29K Buy
14,789
+9,566
+183% +$32.5K ﹤0.01% 5907
2024
Q1
$34K Sell
5,223
-5,540
-51% -$50.3K ﹤0.01% 5694
2023
Q4
$150K Buy
10,763
+4,853
+82% +$76.6K ﹤0.01% 5330
2023
Q3
$144K Buy
5,910
+3,650
+162% +$92.5K ﹤0.01% 5093
2023
Q2
$73K Buy
2,260
+260
+13% +$7.31K ﹤0.01% 5561
2023
Q1
$55K Buy
+2,000
New +$32.4K ﹤0.01% 5572

Other funds holding GNLX

Royal Bank of Canada's GNLX Position: Q1 2026 in Review

Royal Bank of Canada increased its Genelux (GNLX) stake by 26% in Q1 2026, buying an estimated $33 and bringing the position to 58 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7344.

Royal Bank of Canada first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $150K in Q4 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Royal Bank of Canada held 58 shares of Genelux worth $0 as of Q1 2026.
  • Royal Bank of Canada bought 12 Genelux shares in Q1 2026, an estimated $33.
  • Genelux made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7344 holding.
  • Royal Bank of Canada first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
  • Royal Bank of Canada's Genelux position peaked at $150K in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.